Citations

Clear

4847 citation(s) found for "Tu, Eric".

Response to treatment in a prospective national infantile spasms cohort
Coryell, Jason , Nickels, Katherine , Ryan, Nicole, Leister, Erin, Loddenkemper, Tobias , Grinspan, Zachary M. , Hartman, Adam L. , Kossoff, Eric H. , Gaillard, William D. , Mytinger, John R. , Joshi, Sucheta M. , Shellhaas, Renée A. , Sullivan, Joseph , Dlugos, Dennis , Hamikawa, Lorie, Berg, Anne T. , Millichap, J Gordon , Knupp, Kelly G. , Nordli, Douglas R. , Wirrell, Elaine , Millichap, John , Shellhaas, Renée A , Gaillard, William D , Loddenkemper, Tobias , Berg, Anne T , Grinspan, Zachary , Nickels, Katherine C , Coryell, Jason

Mayo Clinic

Annals of Neurology | December 24, 2015 | Volume: 79 | Issue: 3 | Pages: 475-484

10.1002/ana.24594 | PMID 26704170 Get It

ObjectiveInfantile spasms are seizures associated with a severe epileptic encephalopathy presenting in the first 2 years of life, and optimal treatment continues to be debated. This study evaluates early and sustained response to initial treatments and addresses both clinical remission and electrographic resolution of hypsarrhythmia. Secondarily, it assesses whether response to treatment differs by etiology or developmental status.MethodsThe National Infantile Spasms Consortium established a multicenter, prospective database enrolling infants with new diagnosis of infantile spasms. Children were considered responders if there was clinical remission and resolution of hypsarrhythmia that was sustained at 3 months after first treatment initiation. Standard treatments of adrenocorticotropic hormone (ACTH), oral corticosteroids, and vigabatrin were considered individually, and all other nonstandard therapies were analyzed collectively. Developmental status and etiology were assessed. We compared response rates by treatment group using chi‐square tests and multivariate logistic regression models.ResultsTwo hundred thirty infants were enrolled from 22 centers. Overall, 46% of children receiving standard therapy responded, compared to only 9% who responded to nonstandard therapy (p < 0.001). Fifty‐five percent of infants receiving ACTH as initial treatment responded, compared to 39% for oral corticosteroids, 36% for vigabatrin, and 9% for other (p < 0.001). Neither etiology nor development significantly modified the response pattern by treatment group.InterpretationResponse rate varies by treatment choice. Standard therapies should be considered as initial treatment for infantile spasms, including those with impaired development or known structural or genetic/metabolic etiology. ACTH appeared to be more effective than other standard therapies. ANN NEUROL 2016;79:475–484
SCAI expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Interven
Iliescu, Cezar , Herrmann, Joerg , Yang, Eric H. , Charitakis, Konstantinos, Hakeem, Abdul , Tοutouzas, Konstantinos, Leesar, Massoud A. , Marmagkiolis, Konstantinos , Grines, Cindy L. , Çilingiroğlu, Mehmet , Yang, Eric

Mayo Clinic

Catheterization and Cardiovascular Interventions | December 23, 2015 | Volume: 87 | Issue: 5 | Pages: 895-899

10.1002/ccd.26375 | PMID 26700403 Get It

In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on special considerations for cancer patients in the CCL, the Society for Cardiovascular Angiography and Interventions (SCAI) commissioned a consensus group to provide recommendations based on the published medical literature and on the expertise of operators with accumulated experience in the cardiac catheterization of cancer patients. © 2015 Wiley Periodicals, Inc.
A Critical Review of Repurposing Apomorphine for Smoking Cessation
Morales‐Rosado, Joel A. , Cousin, Margot A. , Ebbert, Jon O. , Klee, Eric W. , Morales-Rosado, Joel A

Mayo Clinic

ASSAY and Drug Development Technologies | December 21, 2015 | Volume: 13 | Issue: 10 | Pages: 612-622

10.1089/adt.2015.680 | PMID 26690764 Get It

Evaluation of liver stiffness with magnetic resonance elastography in patients with constrictive pericarditis: Preliminary findings
Fenstad, Eric R. , Dzyubak, Bogdan , Oh, Jae K. , Williamson, Eric E. , Glockner, James F., Young, Phillip M. , Anavekar, Nandan S., Leise, Michael D. , Araoz, Philip A. , Venkatesh, Sudhakar K. , F Glockner, James, Ehman, Richard L. , Dzyubak, Bogdan , Venkatesh, Sudhakar K

Mayo Clinic

Journal of Magnetic Resonance Imaging | December 21, 2015 | Volume: 44 | Issue: 1 | Pages: 81-88

10.1002/jmri.25126 | PMID 26691749 Get It

PurposeTo evaluate with magnetic resonance elastography (MRE) whether patients with constrictive pericarditis (CP) have increased hepatic stiffness. CP results in reduced pericardial compliance, ventricular interdependence, and right heart failure. Patients with untreated CP may develop liver fibrosis and ultimately cirrhosis due to chronic venous congestion. Chronic venous congestion ± fibrosis may lead to increased liver stiffness.Materials and MethodsProspectively, patients with suspected CP underwent 2D transthoracic echocardiography, cardiac MRI, and liver MRE. An automated method was used to draw regions of interest (ROIs) on the stiffness maps to calculate the mean liver stiffness in kilopascals (kPa). A t‐test with α = 0.05 was performed between stiffness values of patients with positive and negative CP findings based on previously published echocardiography criteria.ResultsNineteen patients met inclusion criteria with a mean ± standard deviation (SD) age of 51 ± 16 years. Nine patients (47%) had CP. Mean liver stiffness trended higher in patients with CP compared to those without CP (4.04 kPa vs. 2.46; P = 0.045). Liver stiffness correlated with MRI septal bounce (P = 0.04), inferior vena cava size (P = 0.003), echo abnormal septal motion (P = 0.04), and echo mitral inflow variation >25% (P = 0.02). Only MRI septal bounce predicted CP by echocardiography (P < 0.001).ConclusionCP was associated with increased liver stiffness. The increased stiffness is most likely secondary to chronic hepatic venous congestion and/or fibrosis. MRE may be useful for noninvasive liver stiffness assessment in CP. J. Magn. Reson. Imaging 2016;44:81–88.
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry
Molho, Eric , Stacy, Mark, Gillard, Patrick, Charles, David , Schwartz, Marc , Brin, Mitchell F. , Adler, Charles H. , Jankovic, Joseph J.

Mayo Clinic

Movement Disorders Clinical Practice | December 16, 2015 | Volume: 3 | Issue: 2 | Pages: 130-138

10.1002/mdc3.12238 | PMID 27774495 Get It

Abstract Background Cervical dystonia is thought to result in high disease burden, but limited information exists on its impact on employment and work productivity. We utilized data from the Cervical Dystonia Patient Registry for the Observation of OnabotulinumtoxinA Efficacy (ClinicalTrials.gov identifier: NCT 00836017) to assess the impact of cervical dystonia on employment and work productivity and examine the effect of onabotulinumtoxinA treatments on work productivity. Methods Subjects completed a questionnaire on employment status and work productivity at baseline and final visit. Baseline data were examined by severity of cervical dystonia, predominant subtype, presence of pain, prior exposure to botulinum toxin, and/or utility of a sensory trick. Work productivity results at baseline and final visit were compared in subjects who were toxin‐naïve at baseline and received three onabotulinumtoxinA treatments. Results Of 1,038 subjects, 42.8% were employed full‐ or part‐time, 6.1% unemployed, 32.7% retired, and 11.8% disabled. Of those currently employed, cervical dystonia affected work status of 26.0%, caused 29.8% to miss work in the past month (mean, 5.1 ± 6.4 days), and 57.8% reported decreased productivity. Half of those unemployed were employed when symptoms began, and 38.5% attributed lost employment to cervical dystonia. Pain, increasing severity, and anterocollis/retrocollis had the largest effects on work status/productivity. Preliminary analyses showed that absenteeism and presenteeism were significantly decreased following onabotulinumtoxinA treatments in the subpopulation that was toxin‐naïve at baseline. Conclusions This analysis confirms the substantial negative impact of cervical dystonia on employment, with cervical dystonia‐associated pain being a particularly important driver. OnabotulinumtoxinA treatment appears to improve work productivity.
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke
Ungprasert, Patompong , Matteson, Eric L. , Thongprayoon, Charat

Mayo Clinic

Stroke | December 16, 2015 | Volume: 47 | Issue: 2 | Pages: 356-364

10.1161/strokeaha.115.011678 | PMID 26670086 Get It

Background and Purpose— The association between hemorrhagic stroke and use of nonsteroidal anti-inflammatory drugs (NSAIDs) is not well established. We conducted a systematic review and meta-analysis of observation studies to further characterize this possible association. Methods— Case–control and cohort studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing risk of hemorrhagic stroke among NSAIDs users versus nonusers were systematically searched. Point estimates from each study were extracted. Pooled risk ratios (RR) and 95% confidence intervals (CI) for all NSAIDs and individual NSAIDs were calculated using random-effect, generic inverse variance method. Results— Ten studies were identified and included in our data analysis. As a single group, NSAIDs use was associated with a small but insignificant risk of hemorrhagic stroke with the pooled RR of 1.09 (95% CI, 0.98–1.22). Individual NSAIDs analysis revealed a significantly increased risk among diclofenac and meloxicam users (RR 1.27; 95% CI, 1.02–1.59 and RR 1.27; 95% CI, 1.08–1.50, respectively). The risk estimate for rofecoxib users was higher, but statistically nonsignificant (RR 1.35; 95% CI, 0.88–2.06). Conclusions— Overall, the use of NSAIDs is not associated with an increased risk of hemorrhagic stroke, although this risk was modestly significantly elevated in diclofenac and meloxicam users.
Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus–related oropharyngeal squamous cell carcinoma
Funk, Ryan K., Moore, Eric J. , García, Joaquín J. , Harmsen, William S. , Stoddard, David G. , Vêncio, Eneida Franco , Foote, Robert L. , Price, Katharine A. , Daniel, J.

Mayo Clinic

Head & Neck | December 15, 2015 | Volume: 38 | Issue: S1 | Pages: No page available

10.1002/hed.24298 | PMID 26667985 Get It

AbstractBackgroundFactors predicting locoregional relapse after surgery for oropharyngeal squamous cell carcinoma (SCC) were identified in the pre‐human papillomavirus (HPV) era. We examined whether traditional indications for adjuvant radiotherapy (RT) or adjuvant chemoradiotherapy (CRT) still correlate with locoregional relapse in HPV‐positive patients after transoral robotic surgery (TORS).MethodsRetrospective review of oropharyngeal SCC cases identified patients with HPV‐positive tumors who did not receive adjuvant therapy after TORS despite intermediate or high‐risk features.ResultsMedian follow‐up was 26.7 months (range, 4.9–73.1 months). Five of 25 eligible patients (20%) relapsed at a median 4.8 months (range, 3.2–7.8 months). Two of 18 (11%) intermediate and 3 of 7 (43%) high‐risk patients relapsed. Kaplan–Meier 2‐year locoregional relapse‐free survival estimates for intermediate and high‐risk patients were 88% and 57% (p = .078), respectively.ConclusionTraditional indications for adjuvant RT or CRT were associated with high risk of locoregional relapse in HPV‐positive patients treated with TORS alone. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1674–E1679, 2016
P3‐169: Reduced default network functional connectivity and verbal learning in cognitively unimpaired late middle‐aged and older adults: Exploratory findings from the arizona ApoE cohort study
Beck, Irene , Roontiva, Auttawut, Wroolie, Tonita, Dunbar, Cole, Peshkin, Eric, Bandy, Dan, Rasgon, Nathalie, Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei , Bauer, Robert , Peshkin, Eric

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_15 | Pages: No page available

10.1016/j.jalz.2015.06.1540 Get It

F3‐03‐04: The Alzheimer's prevention initiative: Genetic testing, disclosure, and counseling strategies
Karlawish, Jason , Bradbury, Angela R. , Patrick‐Miller, Linda , Blacker, Deborah , Caselli, Richard J. , Zallen, Doris T. , Marchant, Gary E. , Langlois, Carolyn, Reiman, Eric M. , Tariot, Pierre N. , Langbaum, Jessica B. S. , Roberts, J. Scott , Wood, Elisabeth McCarty , Kim, Scott Y. H.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2015.07.233 Get It

P1‐319: Alzheimer's prevention registry: A shared resource to the scientific community to facilitate enrollment in studies
High, Nellie, Reiman, Eric M. , Aisen, Paul, Albert, Marilyn S. , Comer, Meryl, Petersen, Ronald , Strobel, Gabrielle, Weiner, Michael W. , Tariot, Pierre N. , Langbaum, Jessica B. S. , Cummings, Jeffrey L. , Manly, Jennifer J. , Sperling, Reisa Anne

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2015.06.534 Get It